SeekingAlpha · Aug 7, 2026
Vaxart, Inc. (VXRT) Q2 2026 Earnings Call Transcript
Vaxart, Inc. (VXRT) Q2 2026 Earnings Call August 7, 2026 4:30 PM EDTCompany ParticipantsSteven Lo - President, CEO & DirectorJames Cummings - Chief...
VX
OTC · VXRT
VAXART INC
Healthcare · Biotechnology
$0.52
Up+$0.00 (+0.06%)
Updated Aug 23, 2026, 8:46 AM
SID Score
4.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 87.55M
- P/E ratio
- -1.65
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 172.83K
- Avg. volume
- 545.48K
Price performance
VXRT price history
1M range · 0 trading sessions · Daily adjusted prices
VXRT does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest VXRT news
The latest Smart Investors Daily articles mentioning VXRT.
Stock researchCompany · Overview
VXRT research
Overview
Company profile and research snapshot.
Company profile
VAXART INC
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $2.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Mar 27, 2025 | B. Riley Securities | Buy | — |
| Aug 15, 2024 | Oppenheimer | Outperform | — |
| Jan 31, 2024 | B. Riley Securities | Buy | — |
| Sep 7, 2023 | Cantor Fitzgerald | Overweight | — |
| Aug 7, 2023 | Cantor Fitzgerald | Overweight | — |
News briefing
No generated briefing is available yet.
Yahoo · Jul 30, 2026
Vaxart to Host Stockholder Fireside Chat on August 7 at 4:30 p.m. ET
Company to report second quarter 2026 financial results on August 6 SOUTH SAN FRANCISCO, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform, today announced that members of the Company’s senior management team will participate in a virtual fireside chat on Friday, August 7, 2026, at 4:30 p.m. ET / 1:30 p.m. PT as part of its regular series to answer
SeekingAlpha · May 8, 2026
Vaxart, Inc. (VXRT) Q1 2026 Earnings Call Transcript
Vaxart, Inc. (VXRT) Q1 2026 Earnings Call May 8, 2026 4:30 PM EDTCompany ParticipantsSteven Lo - President, CEO & DirectorJames Cummings - Chief Medical...
Finnhub · May 8, 2026
Transcript : Vaxart, Inc., Q1 2026 Earnings Call, May 08, 2026
Presentation Operator MessageOperator Greetings, and welcome to the Vaxart Stockholder Fireside Chat Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
